154 related articles for article (PubMed ID: 38685134)
1. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
Chauhan A; Chan K; Halfdanarson TR; Bellizzi AM; Rindi G; O'Toole D; Ge PS; Jain D; Dasari A; Anaya DA; Bergsland E; Mittra E; Wei AC; Hope TA; Kendi AT; Thomas SM; Flem S; Brierley J; Asare EA; Washington K; Shi C
CA Cancer J Clin; 2024 Apr; ():. PubMed ID: 38685134
[TBL] [Abstract][Full Text] [Related]
2. [Interpretation and evaluation of the American Joint committee on Cancer (AJCC) 8th Edition Staging System for patients with gastroenteropancreatic neuroendocrine tumors].
Chen L; Zhou Z; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):972-976. PubMed ID: 28900985
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
4. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological Features of Neuroendocrine Tumors in Gastroenteropancreatic Tract: A Single Center Study.
Rafique Z; Qasim A; Zafar A; Ali S; Chughtai AS; Atiq A
Cureus; 2022 Jul; 14(7):e27384. PubMed ID: 36046310
[TBL] [Abstract][Full Text] [Related]
6. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
7. [Chinese expert consensus on gastroenteropancreatic neuroendocrine neoplasms (2022 edition)].
Expert Committee on Neuroendocrine Neoplasms, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2022 Dec; 44(12):1305-1329. PubMed ID: 36575783
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification.
Xu JX; Wu DH; Ying LW; Hu HG
World J Gastroenterol; 2021 Dec; 27(47):8123-8137. PubMed ID: 35068858
[TBL] [Abstract][Full Text] [Related]
9. Survival outcomes used to generate version 9 American Joint Committee on Cancer staging system for anal cancer.
Janczewski LM; Faski J; Nelson H; Gollub MJ; Eng C; Brierley JD; Palefsky JM; Goldberg RM; Washington MK; Asare EA; Goodman KA;
CA Cancer J Clin; 2023; 73(5):516-523. PubMed ID: 37114458
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters.
; Cho MY; Sohn JH; Jin SY; Kim H; Jung ES; Kim MJ; Kim KM; Kim WH; Kim JM; Kang YK; Choi JH; Kang DY; Kim YW; Choi EH
Korean J Pathol; 2013 Jun; 47(3):227-37. PubMed ID: 23837015
[TBL] [Abstract][Full Text] [Related]
11. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
[TBL] [Abstract][Full Text] [Related]
12. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer.
Janczewski LM; Browner AE; Cotler JH; Nelson H; Kakar S; Carr NJ; Hanna NN; Holowatyj AN; Goldberg RM; Washington MK; Asare EA; Overman MJ;
CA Cancer J Clin; 2023; 73(6):590-596. PubMed ID: 37358310
[TBL] [Abstract][Full Text] [Related]
14. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
[TBL] [Abstract][Full Text] [Related]
15. Application of AJCC/UICC and WHO-2010 classifications for GEP-NEN in Chinese patients.
Ye BX; Heng D; Jiang LQ; Wang Y; Zhang HJ; Lin L
J Dig Dis; 2015 May; 16(5):264-71. PubMed ID: 25707298
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.
Xu Z; Wang L; Dai S; Chen M; Li F; Sun J; Luo F
JAMA Netw Open; 2021 Sep; 4(9):e2124750. PubMed ID: 34554237
[TBL] [Abstract][Full Text] [Related]
17. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update.
Kole C; Charalampakis N; Vailas M; Tolia M; Sotiropoulou M; Tsakatikas S; Kouris NI; Tsoli M; Koumarianou A; Karamouzis MV; Schizas D
Cancer Immunol Immunother; 2022 Apr; 71(4):761-768. PubMed ID: 34471940
[TBL] [Abstract][Full Text] [Related]
19. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
20. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs.
Shi M; Fan Z; Xu J; Yang J; Li Y; Gao C; Su P; Wang X; Zhan H
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188637. PubMed ID: 34678439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
